Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NCS Multistage Holdings (NCSM) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for NCS Multistage Holdings (NCSM) over the last 10 years, with Q3 2025 value amounting to $25.3 million.

  • NCS Multistage Holdings' Cash & Equivalents rose 6500.33% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.3 million, marking a year-over-year increase of 6500.33%. This contributed to the annual value of $25.9 million for FY2024, which is 5478.47% up from last year.
  • As of Q3 2025, NCS Multistage Holdings' Cash & Equivalents stood at $25.3 million, which was up 6500.33% from $25.4 million recorded in Q2 2025.
  • In the past 5 years, NCS Multistage Holdings' Cash & Equivalents ranged from a high of $25.9 million in Q4 2024 and a low of $9.9 million during Q3 2022
  • Moreover, its 5-year median value for Cash & Equivalents was $15.5 million (2022), whereas its average is $17.2 million.
  • Within the past 5 years, the most significant YoY rise in NCS Multistage Holdings' Cash & Equivalents was 11359.58% (2021), while the steepest drop was 5553.6% (2021).
  • NCS Multistage Holdings' Cash & Equivalents (Quarter) stood at $22.2 million in 2021, then fell by 26.77% to $16.2 million in 2022, then grew by 2.99% to $16.7 million in 2023, then skyrocketed by 54.78% to $25.9 million in 2024, then decreased by 2.26% to $25.3 million in 2025.
  • Its Cash & Equivalents was $25.3 million in Q3 2025, compared to $25.4 million in Q2 2025 and $23.0 million in Q1 2025.